Collaborations also open the door to vital new research knowledge and technical skills.
"Everyone brings something to the table in successful collaborations: scientific expertise, technologies, skills, contacts and experience," says Dr. Thorsteinsdttir. "For instance, many small firms taking their first steps in product development often need help navigating the regulatory environment."
Developing country biotech firms are increasingly aware of the importance of promoting development and innovation through joint efforts with one another, and have set up networks to deal with malaria, tuberculosis, HIV/AIDS and other common diseases. Brazil, China, Cuba, Nigeria, Russia, Thailand and Ukraine are working together in a network that jointly promotes research and development aimed at developing innovative diagnostics kits, drugs, and vaccines for HIV/AIDS prevention and treatment.
Concludes co-author Peter A. Singer, MD, Director of the MRC: "There are 5 billion brains in the developing world. When they connect, the light bulbs will really start to glow. And the more they work with each other, the less they will depend on the industrialized world."
Further examples, south-south collaborations:
Global south-south-north consortium for clinical cancer trials
Nimotuzumab is cancer therapeutic aimed at various cancer types including esophageal, brain metastasis, colorectal, pancreatic, prostate, cervical and breast. To carry out cost effective clinical trials on nimotuzumab, CIMAB SA (Havana, Cuba), and its partner YM BioSciences (Mississauga, Canada), have established a consortium of mainly small biotech firms from 20 developing c
|Contact: Terry Collins|
McLaughlin-Rotman Centre for Global Health